Novel family of [RuCp(N,N)(P)]

Humans 2,2'-Dipyridyl Carcinoma, Non-Small-Cell Lung Ligands Lung Neoplasms Serum Albumin, Human DNA / chemistry Anti-Bacterial Agents / pharmacology Ethylene Glycols Antineoplastic Agents / pharmacology Ruthenium / pharmacology Coordination Complexes / pharmacology Cell Line, Tumor
Antibacterial activity Anticancer Anticancer activity MRSA Ruthenium-cyclopentadienyl Solution studies

Journal

European journal of medicinal chemistry
ISSN: 1768-3254
Titre abrégé: Eur J Med Chem
Pays: France
ID NLM: 0420510

Informations de publication

Date de publication:
15 Dec 2023
Historique:
received: 29 09 2023
revised: 27 10 2023
accepted: 28 10 2023
medline: 20 11 2023
pubmed: 10 11 2023
entrez: 9 11 2023
Statut: ppublish

Résumé

A family of ten novel ruthenium(II)-cyclopentadienyl organometallics of general formula [Ru(η

Identifiants

DOI: 10.1016/j.ejmech.2023.115922 PMID: 37944388
pubmed: 37944388
pii: S0223-5234(23)00889-9
doi: 10.1016/j.ejmech.2023.115922
pii:
doi:

Substances chimiques

2,2'-Dipyridyl 551W113ZEP
Ligands 0
Serum Albumin, Human ZIF514RVZR
DNA 9007-49-2
Anti-Bacterial Agents 0
Ethylene Glycols 0
Antineoplastic Agents 0
Ruthenium 7UI0TKC3U5
Coordination Complexes 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

115922

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Ricardo G Teixeira (RG)

Centro de Química Estrutural, Institute of Molecular Sciences, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016, Lisboa, Portugal.

János P Mészáros (JP)

Department of Molecular and Analytical Chemistry, Interdisciplinary Excellence Centre, University of Szeged, Dóm tér 7, H-6720, Szeged, Hungary; MTA-SZTE Lendület Functional Metal Complexes Research Group, University of Szeged, Dóm tér 7, H-6720, Szeged, Hungary.

Beatriz Matos (B)

Instituto de Investigação e Inovação em Saúde (i3S), University of Porto, 4200-135, Porto, Portugal; Cancer Drug Resistance Group, Institute of Molecular Pathology and Immunology (IPATIMUP), University of Porto, 4200-135, Porto, Portugal.

Leonor Côrte-Real (L)

Centro de Química Estrutural, Institute of Molecular Sciences, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016, Lisboa, Portugal.

Cristina P R Xavier (CPR)

Instituto de Investigação e Inovação em Saúde (i3S), University of Porto, 4200-135, Porto, Portugal; Cancer Drug Resistance Group, Institute of Molecular Pathology and Immunology (IPATIMUP), University of Porto, 4200-135, Porto, Portugal.

Xavier Fontrodona (X)

Departament de Química and Serveis Tècnics de Recerca, Universitat de Girona, C/ M. Aurèlia Campmany, 69, E-17003, Girona, Spain.

M Helena Garcia (MH)

Centro de Química Estrutural, Institute of Molecular Sciences, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016, Lisboa, Portugal.

Isabel Romero (I)

Departament de Química and Serveis Tècnics de Recerca, Universitat de Girona, C/ M. Aurèlia Campmany, 69, E-17003, Girona, Spain.

Gabriella Spengler (G)

MTA-SZTE Lendület Functional Metal Complexes Research Group, University of Szeged, Dóm tér 7, H-6720, Szeged, Hungary; Department of Medical Microbiology, Albert Szent-Györgyi Health Center and Albert Szent-Györgyi Medical School, University of Szeged, Semmelweis utca 6, 6725, Szeged, Hungary.

M Helena Vasconcelos (MH)

Instituto de Investigação e Inovação em Saúde (i3S), University of Porto, 4200-135, Porto, Portugal; Cancer Drug Resistance Group, Institute of Molecular Pathology and Immunology (IPATIMUP), University of Porto, 4200-135, Porto, Portugal; Department of Biological Sciences, Faculty of Pharmacy of the University of Porto (FFUP), Porto, Portugal.

Ana Isabel Tomaz (AI)

Centro de Química Estrutural, Institute of Molecular Sciences, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016, Lisboa, Portugal.

Éva A Enyedy (ÉA)

Department of Molecular and Analytical Chemistry, Interdisciplinary Excellence Centre, University of Szeged, Dóm tér 7, H-6720, Szeged, Hungary; MTA-SZTE Lendület Functional Metal Complexes Research Group, University of Szeged, Dóm tér 7, H-6720, Szeged, Hungary.

Andreia Valente (A)

Centro de Química Estrutural, Institute of Molecular Sciences, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016, Lisboa, Portugal. Electronic address: amvalente@ciencias.ulisboa.pt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Novel family of [RuCp(N,N)(P)]
questionsmedicales.fr › Composés hétérocycliques › Composés hétéromonocycliques › Pyridines › 2,2'-Bipyridine › Novel family of [RuCp(N,N)(P)]
questionsmedicales.fr › Maladies de l'appareil respiratoire › Tumeurs de l'appareil respiratoire › Tumeurs du poumon › Tumeurs des bronches › Carcinome bronchogénique › Carcinome pulmonaire non à petites cellules › Novel family of [RuCp(N,N)(P)]
questionsmedicales.fr › Actions chimiques et utilisations › Utilisations spécialisées de produits chimiques › Produits chimiques de laboratoire › Ligands › Novel family of [RuCp(N,N)(P)]
questionsmedicales.fr › Maladies de l'appareil respiratoire › Tumeurs de l'appareil respiratoire › Tumeurs du poumon › Novel family of [RuCp(N,N)(P)]
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines du sang › Sérumalbumine › Sérum-albumine humaine › Novel family of [RuCp(N,N)(P)]
questionsmedicales.fr › Acides nucléiques, nucléotides et nucléosides › Acides nucléiques › ADN › Novel family of [RuCp(N,N)(P)]
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Novel family of [RuCp(N,N)(P)]
questionsmedicales.fr › Composés chimiques organiques › Alcools › Glycols › Éthylène glycols › Novel family of [RuCp(N,N)(P)]
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Antinéoplasiques › Novel family of [RuCp(N,N)(P)]
questionsmedicales.fr › Produits chimiques inorganiques › Métaux › Métaux lourds › Ruthénium › Novel family of [RuCp(N,N)(P)]
questionsmedicales.fr › Composés chimiques organiques › Complexes de coordination › Novel family of [RuCp(N,N)(P)]
questionsmedicales.fr › Cellules › Cellules cultivées › Cellules cancéreuses en culture › Lignée cellulaire tumorale › Novel family of [RuCp(N,N)(P)]